This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 11/18/2024 - 10:55 Nov. Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrialfibrillation,” said Christian T.
Early treatment of persistent AF can reduce the risk of bloodclots, stroke, and heart failure, and may prevent the disease from becoming permanent. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024. The company now anticipates U.S. Caution: Investigational Device. Circulation.
Mass screening for atrialfibrillation using ECG together with heart failure biomarker does not prevent ischemic stroke or systemic embolism (bloodclot) in older adults aged 75–76 years over 5 years follow-up, according to late breaking research presented in a Hot Line Session at this year's ESC Congress 2024 in London, UK (30 Aug–2 Sept).
milla1cf Thu, 04/04/2024 - 12:14 April 4, 2024 — Osso VR , a leader in immersive procedural training, announces the release of a co-developed curriculum with the American College of Cardiology ( ACC ). This collaboration expands Osso VR’s presence in the cardiovascular sector.
Results will be presented at the American Heart Association/American Stroke Association ( AHA / ASA ) International Stroke Conference ( ISC ) 2024 in Phoenix.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. Estimates of current and future incidence and prevalence of atrialfibrillation in the U.S.
tim.hodson Thu, 12/19/2024 - 14:35 Dec. 19, 2024 Drinking multiple cups of coffee a day may help prevent cognitive decline in people withatrial fibrillation (AFib or AF), according to new research published in the Journal of the American Heart Association. according to the American Heart Association. Joglar, M.D.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content